US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Nov 22, 2024 (2 years ago)

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Discoloration

What was recalled

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Recalling firm
Provepharm Inc.
NDC code
81284-411-05
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0150-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Dihydroergotamine recalls

See all